Clovis Oncology Inc (NASDAQ:CLVS)

Delayed Data
As of Apr 20
 -1.15 / -2.24%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 86.00, with a high estimate of 110.00 and a low estimate of 72.00. The median estimate represents a +71.42% increase from the last price of 50.17.

Analyst Recommendations

The current consensus among 12 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -21.15%
Growthannually 33.13%


Growthquarterly 59.56%
Growthannually 153.62%
Key to the earnings and sales forecast charts.